SCHEMBL14699352

SCHEMBL14699352

CC(C)CC(=O)N1CCC[C@H]1c1nc(-c2ccc(-c3ccc(C(=O)CN)cc3)cc2)c[nH]1

nearest known ligand 0.39

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.37
CPT1A P50416 8/20 0.36
CPT2 P23786 5/20 0.36
PRCP P42785 3/20 0.35
CYP2C9 P11712 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
DPP4 P27487 1/20 0.35
NR1I2 O75469 1/20 0.34
ABCB11 O95342 1/20 0.34
OPRK1 P41145 1/20 0.34
KCNH2 Q12809 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1985869 0.88 CPT1A (0.34) CYP3A4CPT1ACPT2PRCPKCNH2
SCHEMBL14331346 0.88 PRCP (0.35) CYP3A4CPT1ACPT2PRCPCYP2C9
Hydrochloric Acid SCHEMBL1985931 0.87 CPT1A (0.35) CYP3A4CPT1ACPT2PRCPKCNH2
Hydrochloric Acid SCHEMBL14331283 0.87 CPT1A (0.35) CYP3A4CPT1ACPT2PRCPCYP2C9
SCHEMBL19388693 0.86 CYP3A4 (0.38) CYP3A4CPT1ACPT2PRCPCYP2C9
SCHEMBL21334070 0.85 CYP3A4 (0.37) CYP3A4CPT1ACPT2PRCPCYP2C9
SCHEMBL19414795 0.84 CPT1A (0.41) CPT1ACPT2
SCHEMBL14331249 0.83 CYP3A4 (0.50) CYP3A4PRCPCYP2C9NR1I2ABCB11
SCHEMBL14776865 0.83 CYP3A4 (0.50) CYP3A4PRCPCYP2C9NR1I2ABCB11
SCHEMBL1982625 0.83 CYP3A4 (0.39) CYP3A4PRCPCYP2C9NR1I2ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013025975-A1 COMBINATION TREATMENTS FOR HEPATITIS C GLAXOSMITHKLINE LLC (US) 2013-02-21 WO disclosed